-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Whitehawk Therapeutics with Market Outperform Rating, Announces Price Target of $8

Benzinga·04/16/2026 13:01:20
Listen to the news
Citizens analyst Reni J. Benjamin initiates coverage on Whitehawk Therapeutics (NASDAQ:WHWK) with a Market Outperform rating and announces Price Target of $8.